tirzepatide risk Study flags need to monitor frailty risks with GLP-1 drugs for older adults 20 Possible Tirzepatide Side Effects
Description
Only FDA-approved medications (Mounjaro and Zepbound) are now available for most patients
Because guessing with peptide medications is not a strategy
Tirzepatide is a novel agent that acts as an agonist for both GLP-1 receptors and gastric inhibitory polypeptide (GIP) receptors, another incretin that lowers glucose and appetite
Our guide on how long peptides take to work explains how pharmacokinetic steady states are affected by treatment interruptions
Oxidation damages key residues Tirzepatide contains tryptophan and methionine residues that are particularly susceptible to oxidation
